BFA
KDNY

BlackRock Fund Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BlackRock Fund Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$22.8M Buy
399,298
+48,847
+14% +$2.96M ﹤0.01% 2108
2016
Q3 		$21.8M Buy
350,451
+17,414
+5% +$1.23M ﹤0.01% 2027
2016
Q2 		$18.8M Buy
333,037
+127,497
+62% +$7.75M ﹤0.01% 2057
2016
Q1 		$13.2M Buy
205,540
+19,237
+10% +$1.56M ﹤0.01% 2223
2015
Q4 		$26.2M Buy
186,303
+147,038
+374% +$20M 0.01% 1877
2015
Q3 		$3.8M Sell
39,265
-315
-0.8% -$37.5K ﹤0.01% 2933
2015
Q2 		$6M Buy
+39,580
New +$6.54M ﹤0.01% 2819

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return